The Goldman Sachs Group, Inc. (GS)

Goldman Sachs shares closed at $926.81 on November 11, 2026, up 1.83% on the session, but still 19.69% below the 52-week high of $1,153.99. The stock sits in the middle of its yearly range, just above its 50-day average and below its 200-day average, so the trend picture is mixed rather than clearly up or down. The main near-term question is whether the shares can reclaim the 200-day average of $956.01 and hold above the 20-day EMA of $903.10 while investors weigh a strong earnings run against a slower expected growth rate next year.

Goldman Sachs has beaten the EPS estimate in all eight of the recent reports the record covers. The stock did not follow every beat higher, though. After the October report the shares fell 0.23% in the first session, and across the eight reports the price was lower in the first session three times and higher five times. Investors are clearly paying attention to earnings, but a beat alone has not guaranteed a rally.

Analysts expect revenue to rise 25.8% this fiscal year, and EPS to grow 39.3% to $71.46. Next year the picture changes: the EPS estimate of $74.63 implies growth of only 4.4%. That slowdown is the main reason the analysts' view is cautious even though the current numbers are strong.

The net profit margin is 29.9% and the operating margin is 38.37%, with return on equity at 17.71%, above the sector median of 13.8%. The trailing P/E of 13.33 sits 19.2% below the sector median of 16.5, which the peer benchmarking places broadly in line with peers. The price-to-sales ratio of 3.76 is close to the sector median of 3.8. The debt-to-equity ratio of 7.56 is high, but for a bank it leaves out deposits, so it says less about the balance sheet than it would for an industrial company. The trailing dividend yield is 1.94%, on an annual dividend of $18.00.

Of 26 analysts with a current rating, 9 rate the stock buy or strong buy, 15 hold it and 2 sell or strong sell. Three months ago, 7 of 25 rated it buy. On October 23, 2026, Freedom Broker upgraded the stock to Buy from Hold, while UBS, BMO Capital, JP Morgan, Citigroup and Keefe, Bruyette & Woods all kept their existing ratings in October and early November. The consensus is Hold. Insiders sold $191.2M of stock over the last 18 months across 28 sales and made no open-market purchases. Those sales are often planned in advance or made to cover taxes on vesting shares, so they carry less weight than purchases would.

The base case is a stock that trades within a range while the analysts' figures and the trend pull in different directions. Analysts' average EPS estimate for this fiscal year is $71.46, expected to grow 39.3%, but the estimate for next fiscal year, $74.63, implies only 4.4% growth. For the shares to move meaningfully higher, they would need to clear the 200-day average at $956.01 and then press toward the 52-week high of $1,153.99, which would likely require the earnings momentum to show up in the price. The median analyst target of $1,000.00 sits 7.9% above the current price, and the range runs from $730.00 to $1,250.00. A break below the 20-day EMA at $903.10 would weaken the near-term picture and bring the 52-week low of $754.00 into view as the next reference point. The CleaRank rating of Hold reflects this balance rather than a directional call.

Support sits first at the 20-day exponential moving average of $903.10, which is the nearest level below the price and the one a fall would meet first. Below that, the 52-week low of $754.00 marks the second support level, where the stock last traded at the bottom of its yearly range. Resistance comes first from the 200-day simple moving average at $956.01, which a rise would meet first and which the stock has not yet reclaimed. Beyond it, the 52-week high of $1,153.99 is the second resistance level. The 50-day simple moving average at $926.13 sits almost exactly at the price, so it acts as a pivot rather than a clear barrier.